Abstract:Abstract Background: Defining effective early status of Alzheimer’s disease (AD) could be challenging, due to complexity in linking early and late stages in the progression and the internal biological heterogeneity within same status. We explore whether it is possible to verify and refine candidature early statuses in the AD progressions by comparing the neurological features learned by deep learning models. Methods: We collect functional magnetic resonance imaging (fMRI) data from 432 subjects, including 79 healthy controls (HCs), 109 amnestic mild cognitive impairments (aMCIs), 39 non-amnestic MCIs (naMCIs), 98 subjective cognitive declines (SCDs) and 107 ADs. We train graph convolutional networks (GCNs) based on multiscale functional networks to accurately classify aMCI from naMCI and HC from MCIs. The trained models are applied to AD and SCD groups to suggest the neural feature similarity (as the ratio of predictions) among the statuses and identify clinically informative subpopulations. The corresponding demographics, cognitive assessments, T1, and PET images are used to provide supportive evidences for sub-divided populations based on the model decisions. Results: The GCN model achieves 89.2±1.9% and 83.7±3.1% accuracies in aMCI-vs-naMCI and HC-vs-MCI classifications. The aMCI-vs-naMCI classification model identifies 71.8% of the AD subjects as aMCI. The HC-vs-MCI classification model suggests that 73.5% of the SCDs are MCI, in which 88.8% are further diagnosed as “aMCI” by the aMCI-vs-naMCI classifier. The analyses based on T1 and PET images suggests that the aMCI-like AD exhibits more globally elaborated Aβ depositions, severer glucose metabolism reduction and grey matter atrophy than naMCI-like AD after contrasted with clinical HCs. MCI-like SCD shows more reduction of glucose metabolism than HC-like SCD, baselined by clinical HCs. Further, aMCI-like SCD exhibits slightly elaborated Aβ while naMCI-like SCD shows none when compared to clinical HCs. MCI-like SCD has lower executive ability than HC-like SCD. aMCI-like SCD shows lower memory ability than naMCI-like SCD. Conclusions: This study suggests an overall neurological similarity among SCD, aMCI and AD from perspective of brain dynamics, and verifies the position of SCD and aMCI in the AD progression. Further, it offers a potentially refined progression progress, consisting of aMCI-like SCD, aMCI, and aMCI-like AD dementia. Clinical Trials Registration : The data collection has been registered as “ChiCTR2000036842”.

Longitudinal Study of Early Mild Cognitive Impairment Via Similarity-Constrained Group Learning and Self-Attention Based SBi-LSTM

Attention-based and Micro Designed EfficientNetB2 for Diagnosis of Alzheimer’s Disease

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

Self-calibrated Brain Network Estimation and Joint Non-Convex Multi-Task Learning for Identification of Early Alzheimer's Disease.

Attention-guided 3D CNN With Lesion Feature Selection for Early Alzheimer's Disease Prediction Using Longitudinal sMRI

Machine Learning of Cerebello-Cerebral Functional Networks for Mild Cognitive Impairment Detection

Identification of Early Mild Cognitive Impairment Using Multi-Modal Data and Graph Convolutional Networks.

Multi-modal Self-paced Locality Preserving Learning for Diagnosis of Alzheimer’s Disease

Toward Robust Early Detection of Alzheimer's Disease via an Integrated Multimodal Learning Approach

Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment

Temporal and Spatial Analysis of Alzheimer’s Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network

Verifying and Refining Early Statuses in Alzheimer’s Disease Progression: A Possibility from Deep Feature Comparison

Novel Iterative Attention Focusing Strategy for Joint Pathology Localization and Prediction of MCI Progression.

Double-attention Assisted Multi-task Learning for the Alzheimer’s Disease Prediction from Mild Cognitive Impairment*

Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers

Ensemble of Convolutional Neural Networks and Multilayer Perceptron for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Personalized Functional Connectivity based Spatio-Temporal Aggregated Attention Network for MCI Identification

Identification of mild cognitive impairment using multimodal 3D imaging data and graph convolutional networks

A Pairwise Functional Connectivity Similarity Measure Method Based on Few-Shot Learning for Early MCI Detection.

Characterizing MRI biomarkers for early prediction of amnestic mild cognitive impairment among the community‐dwelling Chinese

Cognitive Function Assessment and Prediction for Subjective Cognitive Decline and Mild Cognitive Impairment.